Ibrutinib Plus R-CHOP Cost-Effective for Young Patients With ABC-DLBCL

Retrieved on: 2024-01-22 17:36:30

Tags for this article:

Click the tags to see associated articles and topics

Ibrutinib Plus R-CHOP Cost-Effective for Young Patients With ABC-DLBCL. View article details on HISWAI: https://www.ajmc.com/view/ibrutinib-plus-r-chop-cost-effective-for-young-patients-with-abc-dlbcl

Excerpt

Although ibrutinib adds to the cost of treatment, its benefits over the long term justify the cost, investigators found.

Article found on: www.ajmc.com

View Original Article